Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5

Vaccine

Volumn 30, Issue 9, 2012, Pages 1583-1593

  Tanabe, Kazuyuki ^a   Arisue, Nobuko ^a   Palacpac, Nirianne M Q ^a,b   Yagi, Masanori ^a   Tougan, Takahiro ^a   Honma, Hajime ^a   Ferreira, Marcelo U ^c   Färnert, Anna ^d   Björkman, Anders ^d   Kaneko, Akira ^d,e   Nakamura, Masatoshi ^f   Hirayama, Kenji ^g   Mita, Toshihiro ^h   Horii, Toshihiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka University   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d KAROLINSKA INSTITUTE   (Sweden)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f DOKKYO MEDICAL UNIVERSITY   (Japan)

^g NAGASAKI UNIVERSITY   (Japan)

^h TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Geographical differentiation; Malaria; Plasmodium falciparum; Polymorphism; SERA5; Vaccine

Indexed keywords

CYSTEINE PROTEINASE; MALARIA VACCINE; SERA5 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ARTICLE; BRAZIL; CHIMPANZEE; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE; GENE FLOW; GENE FREQUENCY; GENE TARGETING; GENETIC ANALYSIS; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GHANA; HAPLOTYPE; HOUSEKEEPING GENE; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPUA NEW GUINEA; PARASITE ISOLATION; PHILIPPINES; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM REICHENOWI; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SIMPLE SEQUENCE REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; SOLOMON ISLANDS; TANZANIA; THAILAND; VANUATU; VENEZUELA;

AFRICA; AMINO ACID SEQUENCE; ANTIGENS, PROTOZOAN; ASIA, SOUTHEASTERN; DNA, PROTOZOAN; GENE FREQUENCY; GENETICS, POPULATION; GEOGRAPHY; HAPLOTYPES; MOLECULAR SEQUENCE DATA; OCEANIA; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SOUTH AMERICA; SPECIES SPECIFICITY;

EID: 84856803841     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.124     Document Type: Article

References (58)

1. WHO. World Malaria Report 2010. WHO Global Malaria Programme. http://whqlibdoc.who.int/publications/2010/9789241564106_eng.pdf.
2. Palacpac N.M., Arisue N., Tougan T., Ishii K.J., Horii T. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate. Vaccine 2011, 29:5837-5845.
3. Delplace P., Fortier B., Tronchin G., Dubremetz J.F., Vernes A. Localization, biosynthesis, processing and isolation of a major 126kDa antigen of the parasitophorous vacuole of Plasmodium falciparum. Mol Biochem Parasitol 1987, 23:193-201.
4. Delplace P., Bhatia A., Cagnard M., Camus D., Colombet G., Debrabant A., et al. Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol Cell 1988, 64:215-221.
5. Bzik D.J., Li W.B., Horii T., Inselburg J. Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol Biochem Parasitol 1988, 30:279-288.
6. Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H., et al. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 2002, 277:47533-47540.
7. Miller S.K., Good R.T., Drew D.R., Delorenzi M., Sanders P.R., Hodder A.N., et al. A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J Biol Chem 2002, 277:47524-47532.
8. Debrabant A., Maes P., Delplace P., Dubremetz J.F., Tartar A., Camus D. Intramolecular mapping of Plasmodium falciparum p126 proteolytic fragments by N-terminal amino acid sequencing. Mol Biochem Parasitol 1992, 53:89-96.
9. Li J., Mitamura T., Fox B.A., Bzik D.J., Horii T. Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47kDa fragment. Parasitol Int 2002, 51:343-352.
10. Hodder A.N., Drew D.R., Epa V.C., Delorenzi M., Bourgon R., Miller S.K., et al. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. J Biol Chem 2003, 278:48169-48177.
11. Yeoh S., O'Donnell R.A., Koussis K., Dluzewski A.R., Ansell K.H., Osborne S.A., et al. Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 2007, 131:1072-1083.
12. Arastu-Kapur S., Ponder E.L., Fonović U.P., Yeoh S., Yuan F., Fonović M., et al. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat Chem Biol 2008, 4:203-213.
13. Blackman M.J. Malarial proteases and host cell egress: an 'emerging' cascade. Cell Microbiol 2008, 10:1925-1934.
14. Okech B.A., Nalunkuma A., Okello D., Pang X.L., Suzue K., Li J., et al. Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda. Am J Trop Med Hyg 2001, 65:912-917.
15. Pratt-Riccio L.R., Sallenave-Sales S., de Oliveira-Ferreira J., da Silva B.T., Guimaraes M.L., Santos F., et al. Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon. Malar J 2008, 7:144.
16. Horii T., Shirai H., Jie L., Ishii K.J., Palacpac N.Q., Tougan T., et al. Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitol Int 2010, 59:380-386.
17. Banic D.M., de Oliveira-Ferreira J., Pratt-Riccio L.R., Conseil V., Goncalves D., Fialho R.R., et al. Immune response and lack of immune response to Plasmodium falciparum P126 antigen and its amino-terminal repeat in malaria-infected humans. Am J Trop Med Hyg 1998, 58:768-774.
18. Pang X.L., Horii T. Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). Vaccine 1998, 16:1299-1305.
19. Pang X.L., Mitamura T., Horii T. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect Immun 1999, 67:1821-1827.
20. Soe S., Singh S., Camus D., Horii T., Druilhe P. Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing. Infect Immun 2002, 70:7182-7184.
21. Okech B., Mujuzi G., Ogawal A., Shirai H., Horii T., Egwang T.G. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children. Am J Trop Med Hyg 2006, 74:191-197.
22. Inselburg J., Bzik D.J., Li W.B., Green K.M., Kansopon J., Hahm B.K., et al. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. Infect Immun 1991, 59:1247-1250.
23. Inselburg J., Bathurst I.C., Kansopon J., Barchfeld G.L., Barr P.J., Rossan R.N. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity. Infect Immun 1993, 61:2041-2047.
24. Inselburg J., Bathurst I.C., Kansopon J., Barr P.J., Rossan R. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant. Infect Immun 1993, 61:2048-2052.
25. Sugiyama T., Suzue K., Okamoto M., Inselburg J., Tai K., Horii T. Production of recombinant SERA proteins of Plasmodium falciparum in Escherichia coli by using synthetic genes. Vaccine 1996, 14:1069-1076.
26. Fox B.A., Xing-Li P., Suzue K., Horii T., Bzik D.J. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Exp Parasitol 1997, 85:121-134.
27. Morimatsu K., Morikawa T., Tanabe K., Bzik D.J., Horii T. Sequence diversity in the amino-terminal 47kDa fragment of the Plasmodium falciparum serine repeat antigen. Mol Biochem Parasitol 1997, 86:249-254.
28. Safitri I., Jalloh A., Tantular I.S., Pusarawati S., Win T.T., Liu Q., et al. Sequence diversity in the amino-terminal region of the malaria-vaccine candidate serine repeat antigen in natural Plasmodium falciparum populations. Parasitol Int 2003, 52:117-131.
29. Pratt-Riccio L.R., Lima-Junior J.C., Carvalho L.J., Theisen M., Espíndola-Mendes E.C., Santos F., et al. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. Am J Trop Med Hyg 2005, 73:1096-1103.
30. Liu Q., Ferreira M.U., Ndawi B.T., Ohmae H., Adagu I.S., Morikawa T., et al. Sequence diversity of serine repeat antigen gene exon II of Plasmodium falciparum in worldwide collected wild isolates. Southeast Asian J Trop Med Publ Health 2000, 31:808-817.
31. Suzue K., Ito M., Matsumoto Y., Tanioka Y., Horii T. Protective immunity induced in squirrel monkeys with recombinant serine repeat antigen (SERA) of Plasmodium falciparum. Parasitol Int 1997, 46:17-25.
32. Healer J., Murphy V., Hodder A.N., Masciantonio R., Gemmill A.W., Anders R.F., et al. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol 2004, 52:159-168.
33. Takala S.L., Coulibaly D., Thera M.A., Batchelor A.H., Cummings M.P., Escalante A.A., et al. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med. 2009, 1:2ra5.
34. Chauhan V.S., Yazdani S.S., Gaur D. Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum. Hum Vaccine 2010, 6:757-762.
35. Tanabe K., Mita T., Jombart T., Eriksson A., Horibe S., Palacpac N., et al. Plasmodium falciparum accompanied the human expansion out of Africa. Curr Biol 2010, 70:1-7.
36. Collins W.E., Skinner J.C., Pappaioanou M., Broderson J.R., Mehaffey P. The sporogonic cycle of Plasmodium reichenowi. J Parasitol 1986, 72:292-298.
37. Dean F.B., Hosono S., Fang L., Wu X., Faruqi A.F., Bray-Ward P., et al. Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci USA 2002, 99:5261-5266.
38. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
39. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
40. Rozas J., Sánchez-DelBarrio J.C., Messeguer X., Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19:2496-2497.
41. Wright S. The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution 1965, 19:395-420.
42. Excoffier L., Smouse P.E., Quattro J.M. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 1992, 131:479-491.
43. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
44. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
45. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
46. Tanabe K., Sakihama N., Hattori T., Ranford-Cartwright L., Goldman I., Escalante A.A., et al. Genetic distance in housekeeping genes between Plasmodium falciparum and Plasmodium reichenowi and within P. falciparum. J Mol Evol 2004, 59:687-694.
47. Fox B.A., Horii T., Bzik D.J. Plasmodium falciparum: fine-mapping of an epitope of the serine repeat antigen that is a target of parasite-inhibitory antibodies. Exp Parasitol 2002, 101:69-72.
48. Anderson T.J., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., et al. Microsatellite markers revel a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 2000, 17:1467-1482.
49. Arisue N., Kawai S., Hirai M., Palacpac N.M.Q., Jia M., Kaneko A., et al. Clues to evolution of the SERA multigene family in 18 Plasmodium species. PLoS ONE 2011, 6:e17775.
50. Tanabe K., Mackay M., Goman M., Scaife J.G. Allelic dimorphism of a surface antigen gene of the malaria parasite Plasmodium falciparum. J Mol Biol 1987, 195:273-287.
51. Dubbeld M.A., Kochen C.H., Thomas A.W. Merozoite surface proteins 2 of Plasmodium reichenowi is a unique mosaic of Plasmodium falciparum allelic forms and species-specific elements. Mol Biochem Parasitol 1998, 92:187-192.
52. Okenu D.M., Thomas A.W., Conway D.J. Allelic lineages of the merozoite surface protein 3 in Plasmodium reichenowi and Plasmodium falciparum. Mol Biochem Parasitol 2000, 109:185-188.
53. Polley S.D., Weedall G.D., Thomas A.W., Golightly L.M., Conway D.J. Orthologous gene sequences of merozoite surface protein 1 (MSP1) from Plasmodium reichenowi and P. gallinaceum confirm an ancient divergence of P. falciparum alleles. Mol Biochem Parasitol. 2005, 142:25-31.
54. Hughes A.L. Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regions. Genetics 1991, 127:345-353.
55. Hughes A.L. Positive selection and interallelic recombination at the merozoite Surface Antigen-l (MSA-1) Locus of Plasmodium falciparum. Mol Biol Evol 1992, 93:381-393.
56. Escalante A.A., Lal A.A., Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 1998, 149:189-202.
57. Polley S.D., Conway D.J. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 2001, 158:1505-1512.
58. Polley S.D., Chokejindachai W., Conway D.J. Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. Genetics 2003, 165:555-561.